Subtype
Cervical Neoplasm
CI-CAN-00004801Explore in graph →
Non-malignant573 active trials4 approved drugs14 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004801Explore in graph →
Clinical trials
2,386 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06182644 | Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors(FAPI) | unknown | N/A | 30 | Guangdong Provincial People's HospitalOTHER | 1 | Jan 22, 2024 | clinicaltrials |
| NCT05084677 | Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer | unknown | Phase 2 | 96 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jan 18, 2024 |
| clinicaltrials |
| NCT04683549 | HPV Serum Level and FDG PET CT in Patients With Cervical Cancer Treated With Radical Radiochemotherapy(HPV-RICCO) | unknown | N/A | 30 | The Greater Poland Cancer CentreOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT05899647 | Point-of-Care Ultraviolet Microscopy for Cervical Cancer Screening | unknown | N/A | 232 | University of ArizonaOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT04903561 | Increase in Response by Offering Self-sampling Devices in Belgian GP Practices to Non-screened Women(BELGSSAR) | unknown | N/A | 1,200 | SciensanoOTHER_GOV | 1 | Nov 24, 2023 | clinicaltrials |
| NCT05588219 | Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer | unknown | Phase 2 | 30 | Yong Zhang,MDOTHER | 1 | Nov 24, 2023 | clinicaltrials |
| NCT05048407 | Sirius in Gynaecological Laparoscopic Surgery | unknown | N/A | 30 | Precision Robotics (Hong Kong) LimitedINDUSTRY | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06136702 | ELEVATE Acceptability Study(ELEVATE AS) | unknown | N/A | 1,048 | University GhentOTHER | 4 | Nov 18, 2023 | clinicaltrials |
| NCT00997009 | Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer(MITO CERV 2) | unknown | Phase 2 | 108 | National Cancer Institute, NaplesOTHER | 1 | Nov 14, 2023 | clinicaltrials |
| NCT04070976 | Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer | unknown | N/A | 82 | National Institute of CancerologíaOTHER_GOV | 1 | Nov 14, 2023 | clinicaltrials |
| NCT02584478 | Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)(AL3818) | unknown | Phase 3 | 294 | Advenchen Laboratories, LLCINDUSTRY | 6 | Nov 8, 2023 | clinicaltrials |
| NCT05125380 | Cervical Cancer Screening by Self-sampling in a Cohort of Younger Women in Ethiopia | unknown | N/A | 1,200 | Lund UniversityOTHER | 1 | Nov 3, 2023 | clinicaltrials |
| NCT06095674 | ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) Study(ITHACA) | unknown | Phase 1 | 30 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT06095882 | Randomized Controlled, Open Clinical Study on Efficacy and Safety of Acupuncture for Bladder Function Recovery After Radical Cervical Cancer Surgery | unknown | N/A | 180 | Qilu Hospital of Shandong UniversityOTHER | 0 | Oct 23, 2023 | clinicaltrials |
| NCT05498597 | AMT-151 in Patients With Selected Advanced Solid Tumours | unknown | Phase 1 | 30 | Multitude Therapeutics Inc.INDUSTRY | 2 | Oct 19, 2023 | clinicaltrials |
| NCT06068387 | A Prospective Study on the Prediction Model of Para-aortic Lymph Node Metastasis | unknown | N/A | 264 | Chongqing University Cancer HospitalOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT03876860 | An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis | unknown | N/A | 118 | Margaret LiottaOTHER | 1 | Oct 5, 2023 | clinicaltrials |
| NCT06015360 | Fat Grafting for Vaginal Stenosis in Gynaelogical Cancer(GRASS) | unknown | N/A | 8 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 5, 2023 | clinicaltrials |
| NCT00923702 | Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India | unknown | Phase 4 | 22,729 | Partha BasuOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05805358 | Hyperpolarized 13C MRI for Cancer Immunotherapy(DNPSPIO) | unknown | Phase 2 | 90 | Chang Gung Memorial HospitalOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT06016868 | Identification of a MOLecuLar Signature in Locally Advanced Cervical Cancer Patients(MOLLY) | unknown | — | 25 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT06015854 | Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II(Vvax) | unknown | Phase 2 | 18 | University Medical Center GroningenOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT05318625 | A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery. | unknown | N/A | 30 | Precision Robotics (Hong Kong) LimitedINDUSTRY | 1 | Aug 3, 2023 | clinicaltrials |
| NCT05690906 | Evaluate the Effect of ReSpace™ Hydrogel on Reducing Rectal Radiation Dose in Radiotherapy for Cervical Cancer | unknown | Phase 2 | 100 | Peking Union Medical College HospitalOTHER | 1 | Jul 6, 2023 | clinicaltrials |
| NCT05931354 | Longitudinal HPV Pap in CIN and VAIN(LHPCV) | unknown | — | 600 | Chang Gung Memorial HospitalOTHER | 1 | Jul 5, 2023 | clinicaltrials |
| NCT05902390 | The Long-term Benefit of Hydrogel Spacer in Reducing Rectal Radiation Dose in Cervical Cancer Radiation Therapy. | unknown | N/A | 106 | Peking Union Medical College HospitalOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05904977 | Preliminary Study on the Metastatic Rate and Clinical Significance of the Anterior Leaf of Vesicouterine Ligament in Early Stage Cervical Cancer | unknown | — | 460 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05883670 | Real-world Study of Serplulimab in 2L and Above Treatment of Cervical Cancer | unknown | — | 118 | Shandong UniversityOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05879796 | Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer | unknown | — | 30 | Peking University Third HospitalOTHER | 0 | May 30, 2023 | clinicaltrials |
| NCT05606263 | Efficacy and Safety of Caldonirimab Plus Nimotuzumab for Recurrent or Metastatic Cervical Cancer(GCR-05) | unknown | Phase 2 | 55 | Xi'an Jiaotong UniversityOTHER | 1 | May 26, 2023 | clinicaltrials |
| NCT05863260 | Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical Cancer | unknown | — | 60 | Fudan UniversityOTHER | 1 | May 18, 2023 | clinicaltrials |
| NCT05863377 | Efficacy of Chemotherapy Alone in Patients With Poor-differentiated Early-stage Cervical Cancer | unknown | — | 450 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 18, 2023 | clinicaltrials |
| NCT05851079 | Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions | unknown | — | 15,000 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05824494 | Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors | unknown | Phase 2 | 58 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 0 | May 6, 2023 | clinicaltrials |
| NCT05812677 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Apr 14, 2023 | clinicaltrials |
| NCT05806125 | Clinical Value of the Fertility-preserving Surgery in Cervical Cancer | unknown | — | 100 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Apr 10, 2023 | clinicaltrials |
| NCT05393440 | First-in-human (FIH) Phase I Trial of BS-006 in Cervical Cancer(CC-OV01) | unknown | Phase 1 | 18 | Zhongnan HospitalOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT05793749 | Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy | unknown | N/A | 400 | Chongqing University Cancer HospitalOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT00492778 | Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer | unknown | Phase 2 | 165 | GOG FoundationNETWORK | 2 | Mar 29, 2023 | clinicaltrials |
| NCT05789628 | Discovering Factors in Cervical Cancer Patients' Clinical Trial Experiences | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Mar 29, 2023 | clinicaltrials |
| NCT02599116 | Gastrointestinal Microbiome Study of Appendiceal Cancer | unknown | N/A | 24 | Mercy Medical CenterOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT01881659 | Cervical Cancer Screening With Human Papillomavirus Testing(ESTAMPA) | unknown | — | 50,000 | International Agency for Research on CancerOTHER | 9 | Mar 14, 2023 | clinicaltrials |
| NCT05193669 | Clinical Validation of Molecular Triage in HR-HPV Positive Women(VALTRIHP) | unknown | — | 23,941 | Hiantis SrlINDUSTRY | 1 | Feb 8, 2023 | clinicaltrials |
| NCT04689178 | Cervical Cancer Screening Uptake: A Randomised Controlled Trial Assessing the Effect of Sending Invitation Letters to Nonadherent Women(IMPACTGP) | unknown | N/A | 195,000 | Nantes University HospitalOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT04704908 | Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m) | unknown | — | 979 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04969445 | The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 647 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05045755 | The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 1,339 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05446883 | QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer | unknown | Phase 3 | 498 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 30, 2022 | clinicaltrials |
| NCT03049553 | Trial23 - A Method Study on Cervical Screening in Women Offered HPV-vaccination as Girls | unknown | N/A | 7,000 | University of CopenhagenOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT05602831 | Assessment of Prognosis Using Peripheral Blood Circulating Tumor DNA in Patients With Cervical Cancer | unknown | — | 108 | Fudan UniversityOTHER | 1 | Nov 2, 2022 | clinicaltrials |
Data updated 22 days agoSource updated Jan 22, 2024source: clinicaltrials